Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Visual Morbidity in Ocular Tuberculosis - Collaborative Ocular Tuberculosis Study (COTS)-1: Report #6.
Agrawal R MD, FCRS, Gunasekeran DV MBBS, Agarwal A MS, Testi I MD, Carreño E MD, Westcott M FRCOphth, Mahajan S MBBS, Raje D PhD, Aggarwal K MS, Murthy SI DNB, Chee SP FRCSEd, Mccluskey P MD, Ho SL FRCSGlasg, Teoh S FRCSEd, Cimino L MD, Biswas J MS, Narain S MD, Agarwal M MS, Mahendradas P DNB, Khairallah M MD, Jones N FRCSOphth, Tugal-Tutkun I MD, Babu K DNB, Basu S MS, Lee R PhD, Al-Dhibi H MD, Bodaghi B MD, Invernizzi A MD, Goldstein DA MD, Herbort CP MD, Barisani-Asenbauer T PhD, González-López JJ PhD, Androudi S MD, Bansal R MS, Moharana B MS, Esposti SD MD, Tasiopoulou A MD, Nadarajah S MD, Agarwal M DNB, Abraham S MD, Vala R MD, Singh R MS, Sharma A MD, Sharma K PhD, Zierhut M PhD, Kon OM MRCP, Cunningham ET PhD, Kempen JH PhD, Nguyen QD PhD, Pavesio C FRCSOphth, Gupta V MS. Agrawal R MD, FCRS, et al. Among authors: khairallah m md. Ocul Immunol Inflamm. 2020 Sep 30;28(sup1):49-57. doi: 10.1080/09273948.2020.1774905. Epub 2020 Jun 30. Ocul Immunol Inflamm. 2020. PMID: 32600169
The Collaborative Ocular Tuberculosis Study (COTS)-1: A Multinational Review of 165 Patients with Tubercular Anterior Uveitis.
Agrawal R MD FCRS, Betzler B MBBS, Testi I MD, Mahajan S MBBS, Agarwal A MS, Gunasekeran DV MD, Raje D PhD, Aggarwal K MS, Murthy SI DNB, Westcott M FRCSOphth, Chee SP FRCSEd, Mccluskey P MD, Ho SL FRCSGlasg, Teoh S FRCSEd, Cimino L MD, Biswas J MS, Narain S MD, Agarwal M MS, Mahendradas P DNB, Khairallah M MD, Jones N FRCSOphth, Tugal-Tutkun I MD, Babu K DNB, Basu S MS, Carreño E MD, Lee R PhD, Al-Dhibi H MD, Bodaghi B MD, Invernizzi A MD, Goldstein DA MD, Herbort CP MD, Barisani-Asenbauer T PhD, González-López JJ PhD, Androudi S MD, Bansal R MS, Moharana B MS, Esposti S MD, Tasiopoulou A MD, Nadarajah S MD, Agarwal M DNB, Abraham S MD, Vala R MD, Singh R MS, Sharma A MD, Sharma K PhD, Zierhut M PhD, Kon OM MRCP, Cunningham ET PhD, Kempen JH PhD, Nguyen QD PhD, Pavesio C FRCSOphth, Gupta V MS. Agrawal R MD FCRS, et al. Among authors: khairallah m md. Ocul Immunol Inflamm. 2020 Sep 30;28(sup1):17-26. doi: 10.1080/09273948.2020.1761400. Epub 2020 Jun 30. Ocul Immunol Inflamm. 2020. PMID: 32600163
Safety and Efficacy of Gevokizumab in Patients with Behçet's Disease Uveitis: Results of an Exploratory Phase 2 Study.
Tugal-Tutkun I Md, Kadayifcilar S Md, Khairallah M Md, Lee SC Md PhD, Ozdal P, Özyazgan Y, Song JH Md, Yu HG Md PhD, Lehner V PhD, de Cordoue A Md, Bernard O Md, Gül A Md. Tugal-Tutkun I Md, et al. Among authors: khairallah m md. Ocul Immunol Inflamm. 2017 Feb;25(1):62-70. doi: 10.3109/09273948.2015.1092558. Epub 2016 Jan 30. Ocul Immunol Inflamm. 2017. PMID: 26829647 Clinical Trial.